About Jeffrey Young
Jeffrey Young is a director at ABLi Therapeutics.
Experience
This experience comes from SEC filings. The years are when the filings name Jeffrey Young in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Jeffrey Young works with at each company, as listed on that company's latest Form D.
ABLi Therapeutics, Inc. · Form D, Jan 13, 2026
MW
Milton Werner
Chief Executive Officer, President, and Secretary, director
GR
Garth Lees-Rolfe
Chief Financial Officer and Treasurer
AD
Anastasia Daifotis
Director